Related Experiment Videos
Macrophage-neoplastic cell interactions: implications for neoplastic cell growth
1Department of Zoology, Aberdeen University, UK.
FEMS Microbiology Immunology
|December 1, 1992
Summary
Dexamethasone treatment reduced inflammation and immune cell infiltration in mice with EL4 lymphoma transplants, inhibiting tumor growth by suppressing macrophage-driven fibroblast growth factor production and associated tissue remodeling.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- Subcutaneous transplantation of EL4 lymphoma cells in C57BL10 mice triggers an inflammatory response, including leukopoiesis, leukocytosis, and connective tissue remodeling (fibroplasia, angiogenesis).
- EL4 lymphoma cells produce factors stimulating Colony Stimulating Factor and monocyte-macrophage lineage chemotaxis, but not directly fibroblast growth factors.
Purpose of the Study:
- To investigate the effects of dexamethasone on the inflammatory response and growth of subcutaneous EL4 lymphoma transplants in C57BL10 mice.
- To elucidate the mechanisms by which dexamethasone influences macrophage activity and connective tissue remodeling in the context of lymphoma growth.
Main Methods:
- Subcutaneous transplantation of EL4 lymphoma cells into C57BL10 mice.
- Administration of dexamethasone to assess its impact on circulating leukocytes, inflammatory infiltrate, and transplant growth.
- In vitro studies to evaluate the direct effects of dexamethasone on fibroblasts and its influence on macrophage-EL4 cell interactions regarding fibroblast growth factor production.
Main Results:
- Dexamethasone significantly reduced circulating blood leukocytes and the inflammatory response to EL4 lymphoma transplants.
- A decreased influx of inflammatory leukocytes into the transplant site correlated with reduced transplant growth in dexamethasone-treated mice.
- Dexamethasone suppressed the production/activity of fibroblast growth factors generated by macrophage-EL4 cell interactions in vitro, without directly inhibiting fibroblast growth.
Conclusions:
- Dexamethasone inhibits EL4 lymphoma transplant growth by reducing macrophage infiltration and suppressing the production of macrophage-derived fibroblast growth factors.
- The anti-inflammatory and anti-angiogenic effects of dexamethasone on the tumor microenvironment contribute to its inhibitory action on lymphoma progression.
- These findings highlight the role of macrophage-mediated inflammation and tissue remodeling in supporting lymphoma growth and suggest therapeutic potential for dexamethasone in managing such conditions.